Home / Safety / DeepSeek for pharmaceutical industry
DeepSeekHow safe is DeepSeek for the pharmaceutical industry?
DeepSeek has a specific GDPR concern. The DeepSeek service stores personal data in China and was blocked by the Italian regulator in 2025. Not recommended for regulated sectors unless you host the model yourself within the EU. Weigh this heavily before deploying it in the pharmaceutical industry.
Where does DeepSeek stand in the pharmaceutical industry?
Shared place 19 of 25 options for the pharmaceutical industry (professional tools and general assistants) on GDPR profile. 7 options, like DeepSeek's profile, are marked Caution. Each tile is an option we track for this field; click through for the check.
Published safeguards
The DeepSeek service stores data in China and uses it for training by default (with an opt-out). Only an EU self-hosted variant of the open weights is defensible for sensitive data.
How to use DeepSeek safely
- Use the business variant and sign a data processing agreement (DPA).
- Do not enter unnecessary personal data into prompts; anonymise where possible.
- Ask the provider explicitly where data is stored and processed.
- Keep a professional in the loop: in this sector it concerns health data of trial participants and patients (special category personal data under art.
Stronger or equally strong in the pharmaceutical industry
CradleCradle (Amsterdam, the Netherlands and Zürich, Switzerland)CastorCastor (Amsterdam, Netherlands)BiolevateBiolevate (Paris, France)Aily LabsAily Labs GmbH (Munich, Germany)ClaudeAnthropicLatest developments
On 21 August 2026, DeepSeek launched an experimental multimodal version of V4 Flash (V4-Flash-Vision-Exp) that processes text and images as input. The model is available exclusively via the hosted API (no open weights); calls are processed on servers in China. There is no EU adequacy decision for China, and DeepSeek has not published Standard Contractual Clauses for EU transfers. For applications where personal data is entered, including via images, such as invoices, patient documents or identity documents, direct API use is not GDPR-defensible. GDPR-compliant alternatives: (1) waiting for open weights and self-hosting on EU infrastructure, (2) use via Microsoft Azure AI Foundry with EU data residency (available for earlier DeepSeek variants). Price: $0.22/$0.66 per million tokens (off-peak), double rate at peak times. source
DeepSeek V4 Pro 0813 moved out of preview to general availability on 13 August 2026. The model (1.6T parameters MoE, 1M context window) is available via the official DeepSeek API at $0.435 per 1M input tokens, but DeepSeek has announced a significant price increase in the near future. GDPR relevance: the cloud API stores data in China; there is no EU adequacy decision. For business use: (1) EU self-hosting on open weights, or (2) use via Microsoft Azure Foundry (EU residency available since May 2026) are the GDPR-defensible routes. Direct API use by organisations in regulated sectors (healthcare, legal, financial) remains not recommended. source
The Garante imposed a processing restriction on DeepSeek over inadequate answers on data processing and storage in China. source
Questions
- How safe is DeepSeek for the pharmaceutical industry?
- DeepSeek has a concrete GDPR concern. The DeepSeek service stores personal data in China and was blocked by the Italian regulator in January 2025. Not advisable for regulated sectors, unless you host the model yourself within the EU. Weigh this heavily before deploying it in the pharmaceutical industry. There is a concrete GDPR concern, read the details on the page.
- Does DeepSeek train on my data?
- The DeepSeek service stores data in China and uses it for training by default (with an opt-out). Only an EU self-hosted variant of the open weights is defensible for sensitive data.
- What should I look out for with AI in the pharmaceutical industry?
- This sector involves health data of trial participants and patients (special category personal data under Article 9 GDPR) and confidential research data. Ask every provider where the data is stored and whether it is used to train models: Castor hosts in the Netherlands (Google Cloud europe-west4) and does not share data or models between customers, Cradle states that source data never goes to third-party AI models, Iris.ai hosts on AWS in Ireland and Germany. Biolevate and Ennov also run in private cloud or on-premises. With Veeva Vault AI and Yseop, texts go to Anthropic models via Amazon Bedrock; check the region and the data processing agreement. If you work in GxP processes, an AI tool must also be validated (EU GMP Annex 11) and a competent employee remains responsible. For AI in medicines development, the EMA has a reflection paper (2024) and is working with the FDA on joint principles.
Source documents
Everything about DeepSeek Best AI for the Pharmaceutical Industry
Summarised by the editorial team from provider documentation · not legal advice
Last checked: 23 October 2026 · How we check
Source: , checked on 23 October 2026
Every Friday: what changed in AI for the pharmaceutical industry
New models, prices, oversight and tools, with sources and what it means for you. One email a week, unsubscribe with one click.